Results 121 to 130 of about 14,484 (178)

Which surfactant is cost-effective in Neonatal Respiratory Distress Syndrome? [PDF]

open access: yesCost Eff Resour Alloc
Nikakhtar G   +4 more
europepmc   +1 more source

Evidence Synthesis via Indirect Treatment Comparisons in the European Framework of Joint Clinical Assessment. [PDF]

open access: yesEpidemiologia (Basel)
Cuadra-Grande A   +4 more
europepmc   +1 more source

Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning.

open access: yesJAMA Netw Open
Shanmugam H   +4 more
europepmc   +1 more source

Pharmacoequity in Anticoagulation Among Medicare Patients With Venous Thromboembolism.

open access: yesJAMA Netw Open
Alkhalaf AA   +4 more
europepmc   +1 more source

Interventional Pharmacoeconomics

The Cancer Journal, 2020
Abstract The increasing cost of health care is a major challenge around the world, but particularly in the United States. One reason for increased costs is the rapidly rising cost of oncology drugs. Potential solutions to this problem involve broad changes to health policy. However, an alternative solution is the development of lower-cost off-
Daniel A, Goldstein   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy